Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.072 | 0.8 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |